Tumor Necrosis Factor-α in Inflammatory Myopathies: Pathophysiology and Therapeutic Implications
- 1 December 2006
- journal article
- review article
- Published by Elsevier in Seminars in Arthritis and Rheumatism
- Vol. 36 (3) , 168-172
Abstract
No abstract availableKeywords
This publication has 33 references indexed in Scilit:
- Infiltrating cells, related cytokines and chemokine receptors in lesional skin of patients with dermatomyositisBritish Journal of Dermatology, 2004
- Polymyositis and dermatomyositisThe Lancet, 2003
- Possible pathogenic mechanisms in inflammatory myopathiesRheumatic Disease Clinics of North America, 2002
- Associations of Tumor Necrosis Factor α and HLA Polymorphisms with Adult Dermatomyositis: Implications for a Unique Pathogenesi1Journal of Investigative Dermatology, 2002
- Matrix metalloproteinases in inflammatory myopathies: enhanced immunoreactivity near atrophic myofibersActa Neurologica Scandinavica, 2002
- Progress in inflammatory myopathies: good but not good enoughJournal of Neurology, Neurosurgery & Psychiatry, 2001
- Immunolocalization of tumor necrosis factor-alpha and its receptors in inflammatory myopathies1This paper was presented at the 50th Annual Meeting of the American Academy of Neurology, Minneapolis, MN, USA, April 1998.1Neuromuscular Disorders, 1999
- Expression of tumor necrosis factor-α in muscles of polymyositisJournal of the Neurological Sciences, 1997
- Cytokine Expression Profile in Idiopathic Inflammatory MyopathiesJournal of Neuropathology & Experimental Neurology, 1996
- ELEVATED SERUM LEVELS OF INTERLEUKIN‐1 RECEPTOR ANTAGONIST IN POLYMYOSITIS/DERMATOMYOSITIS. A Biologic Marker of Disease Activity with a Possible Role in the Lack of Acute‐Phase Protein ResponseArthritis & Rheumatism, 1994